Skip to search.
 FTSE 100 Up 0.62%
Streaming
Ticker Tape: On

More On MSLI

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Merus Labs International Inc. (MSLI)

-NasdaqCM
1.43 Up 0.05(3.62%) 17 Apr 21:00
Add to Portfolio
Prev Close:1.38
Open:1.41
Bid:1.42 x 900
Ask:1.70 x 100
1y Target Est:2.98
Beta:0.83
Next Earnings Date:N/A
Day's Range:1.41 - 1.46
52wk Range:0.46 - 2.15
Volume:4,029
Avg Vol (3m):19,943
Market Cap:54.90m
P/E (ttm):N/A
EPS (ttm):-0.15
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for MSLI at this time.

Key Statistics

Forward P/E (1 yr):7.94
P/S (ttm):1.83
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-0.01
Quarterly EPS Est (Mar-14) :-0.01
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merus Labs International Inc., a specialty pharmaceutical company, is engaged in the acquisition and licensing of branded prescription medicines in the United States, Canada, and Europe. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback